share_log

NAMSA, InspireMD Announce Strategic Outsourcing Partnership To Accelerate New Product Development; Terms Not Disclosed

Benzinga Real-time News ·  Sep 8, 2022 09:02

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard Embolic Prevention System (EPS) for treatment of carotid artery disease and prevention of stroke, announced today that they have entered into a strategic outsourcing partnership to accelerate medical device development and commercialization.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment